<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Two uncommon <z:e sem="disease" ids="C0018671" disease_type="Neoplastic Process" abbrv="">tumors of the head and neck</z:e> first revealed primary roles for two classes of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> genes (oncogenes, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor genes) in the origin of human <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>In Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> the initiating event is a chromosomal translocation that leads to unregulated expression of an oncogene (MYCC), whereas <z:hpo ids='HP_0009919'>retinoblastoma</z:hpo> involves loss of function of both copies of a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor gene (RB1) </plain></SENT>
<SENT sid="2" pm="."><plain>In <z:hpo ids='HP_0002669'>osteosarcoma</z:hpo> the RB1 gene is often affected, as is the gene (TP53) that codes for the p53 protein </plain></SENT>
<SENT sid="3" pm="."><plain>TP53 is frequently mutated in <z:mp ids='MP_0002038'>carcinomas</z:mp> of the head and neck, as in one of the ras oncogenes </plain></SENT>
<SENT sid="4" pm="."><plain>Multiple genetic changes typify <z:mp ids='MP_0002038'>carcinomas</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>Some <z:mp ids='MP_0002038'>carcinomas</z:mp> of the head and neck contain one of the human <z:mpath ids='MPATH_445'>papilloma</z:mpath> viruses that produce proteins that combine with and inactivate p53 and pRB proteins, rendering mutations in these genes unnecessary </plain></SENT>
</text></document>